Human And Animal Blood Market

The global market for human blood and animal blood prepared for therapeutic, prophylactic or diagnostic uses is projected to show continued growth in both volume and value over the next eight years. The market is expected to experience a steady increase, with forecasted CAGR of +4.8% in volume and +7.6% in value from 2022 to 2030. In 2022, consumption of human and animal blood increased by 1%, reaching 226K tons after a period of decline. The market value declined slightly to $20.6B in 2022. The top consuming countries in 2022 were China, United States, and India, while the top producers were China, United States, and India. Import and export trends also showed fluctuations, with notable growth in some countries like Canada and Uruguay. Overall, the market is expected to see growth in both production and consumption, with varying trends in different regions.

Market Forecast

Driven by increasing demand for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses worldwide, the market is expected to continue an upward consumption trend over the next eight years. Market performance is forecast to accelerate, expanding with an anticipated CAGR of +4.8% for the period from 2022 to 2030, which is projected to bring the market volume to 329K tons by the end of 2030.

In value terms, the market is forecast to increase with an anticipated CAGR of +7.6% for the period from 2022 to 2030, which is projected to bring the market value to $37B (in nominal prices) by the end of 2030.

Consumption

World Consumption of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

In 2022, consumption of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses increased by 1% to 226K tons, rising for the second consecutive year after three years of decline. The total consumption volume increased at an average annual rate of +1.3% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. Over the period under review, global consumption attained the peak volume at 291K tons in 2017; however, from 2018 to 2022, consumption remained at a lower figure.

The global human and animal blood market size declined slightly to $20.6B in 2022, shrinking by -2.5% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). The market value increased at an average annual rate of +2.1% from 2012 to 2022; however, the trend pattern remained relatively stable, with somewhat noticeable fluctuations throughout the analyzed period. Global consumption peaked at $22.3B in 2017; however, from 2018 to 2022, consumption remained at a lower figure.

Consumption By Country

The countries with the highest volumes of consumption in 2022 were China (43K tons), the United States (28K tons) and India (15K tons), with a combined 38% share of global consumption. Canada, France, the UK, Pakistan, Japan, Russia, Mexico, Denmark, Spain and Poland lagged somewhat behind, together accounting for a further 33%.

From 2012 to 2022, the biggest increases were recorded for Canada (with a CAGR of +11.3%), while consumption for the other global leaders experienced more modest paces of growth.

In value terms, the United States ($4.3B), China ($3.6B) and Japan ($1.2B) constituted the countries with the highest levels of market value in 2022, with a combined 44% share of the global market. India, France, the UK, Pakistan, Denmark, Canada, Russia, Poland, Mexico and Spain lagged somewhat behind, together comprising a further 23%.

Canada, with a CAGR of +16.1%, saw the highest rates of growth with regard to market size in terms of the main consuming countries over the period under review, while market for the other global leaders experienced more modest paces of growth.

In 2022, the highest levels of human and animal blood per capita consumption was registered in Denmark (905 kg per 1000 persons), followed by Canada (304 kg per 1000 persons), France (164 kg per 1000 persons) and the UK (138 kg per 1000 persons), while the world average per capita consumption of human and animal blood was estimated at 29 kg per 1000 persons.

In Denmark, human and animal blood per capita consumption increased at an average annual rate of +6.1% over the period from 2012-2022. In the other countries, the average annual rates were as follows: Canada (+10.1% per year) and France (+8.1% per year).

Production

World Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

In 2022, production of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses was finally on the rise to reach 202K tons for the first time since 2017, thus ending a four-year declining trend. Overall, production continues to indicate a relatively flat trend pattern. The pace of growth appeared the most rapid in 2013 with an increase of 13%. Over the period under review, global production reached the peak volume at 278K tons in 2017; however, from 2018 to 2022, production stood at a somewhat lower figure.

In value terms, human and animal blood production declined modestly to $19B in 2022 estimated in export price. The total output value increased at an average annual rate of +2.7% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth appeared the most rapid in 2018 with an increase of 11% against the previous year. As a result, production reached the peak level of $19.5B. From 2019 to 2022, global production growth remained at a somewhat lower figure.

Production By Country

The countries with the highest volumes of production in 2022 were China (43K tons), the United States (34K tons) and India (17K tons), with a combined 47% share of global production. Pakistan, the UK, Japan, France, Russia, Denmark, Spain, the Netherlands, Mexico and Iran lagged somewhat behind, together comprising a further 31%.

From 2012 to 2022, the biggest increases were recorded for the Netherlands (with a CAGR of +32.3%), while production for the other global leaders experienced more modest paces of growth.

Imports

World Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

In 2022, global imports of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses shrank sharply to 71K tons, dropping by -36.9% against the previous year. Over the period under review, total imports indicated a noticeable increase from 2012 to 2022: its volume increased at an average annual rate of +2.6% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth appeared the most rapid in 2015 with an increase of 32%. Over the period under review, global imports attained the peak figure at 113K tons in 2021, and then shrank dramatically in the following year.

In value terms, human and animal blood imports dropped remarkably to $7.9B in 2022. In general, imports, however, continue to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2021 when imports increased by 24% against the previous year. As a result, imports attained the peak of $13.2B, and then dropped notably in the following year.

Imports By Country

In 2022, Canada (14K tons), distantly followed by France (6.6K tons), the United States (4.8K tons) and Sweden (3.3K tons) represented the main importers of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, together comprising 40% of total imports. Guatemala (3K tons), Austria (2.9K tons), Brazil (2.9K tons), Australia (2.1K tons), Poland (2.1K tons), the UK (2K tons), Spain (1.7K tons), Ecuador (1.5K tons) and Germany (1.4K tons) held a minor share of total imports.

From 2012 to 2022, average annual rates of growth with regard to human and animal blood imports into Canada stood at +10.3%. At the same time, Guatemala (+94.7%), Ecuador (+26.3%), Australia (+11.1%), Sweden (+8.1%), Poland (+7.3%), France (+4.0%), Spain (+2.2%) and the United States (+1.5%) displayed positive paces of growth. Moreover, Guatemala emerged as the fastest-growing importer imported in the world, with a CAGR of +94.7% from 2012-2022. Brazil and the UK experienced a relatively flat trend pattern. By contrast, Austria (-4.2%) and Germany (-7.5%) illustrated a downward trend over the same period. While the share of Canada (+9.9 p.p.), Guatemala (+4.3 p.p.), Ecuador (+1.9 p.p.), Sweden (+1.9 p.p.) and Australia (+1.6 p.p.) increased significantly in terms of the global imports from 2012-2022, the share of Germany (-3.6 p.p.) and Austria (-4.1 p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest human and animal blood importing markets worldwide were the United States ($1.1B), Sweden ($614M) and the UK ($574M), with a combined 29% share of global imports. France, Canada, Germany, Guatemala, Australia, Brazil, Spain, Ecuador, Austria and Poland lagged somewhat behind, together accounting for a further 27%.

Guatemala, with a CAGR of +79.3%, saw the highest growth rate of the value of imports, among the main importing countries over the period under review, while purchases for the other global leaders experienced more modest paces of growth.

Import Prices By Country

The average human and animal blood import price stood at $111,541 per ton in 2022, waning by -5% against the previous year. Over the period under review, the import price recorded a noticeable downturn. The pace of growth was the most pronounced in 2020 an increase of 30% against the previous year. Over the period under review, average import prices hit record highs at $138,905 per ton in 2012; however, from 2013 to 2022, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was the UK ($291,022 per ton), while Austria ($14,217 per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by France (+9.6%), while the other global leaders experienced more modest paces of growth.

Exports

World Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

In 2022, approx. 47K tons of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses were exported worldwide; falling by -39.4% compared with the previous year's figure. In general, total exports indicated mild growth from 2012 to 2022: its volume increased at an average annual rate of +1.6% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports decreased by -40.3% against 2018 indices. The growth pace was the most rapid in 2017 with an increase of 38% against the previous year. Over the period under review, the global exports attained the peak figure at 78K tons in 2018; however, from 2019 to 2022, the exports remained at a lower figure.

In value terms, human and animal blood exports contracted significantly to $6.3B in 2022. Overall, exports, however, posted a perceptible expansion. The most prominent rate of growth was recorded in 2021 with an increase of 49%. As a result, the exports reached the peak of $14.8B, and then reduced sharply in the following year.

Exports By Country

In 2022, the United States (11K tons), distantly followed by the Netherlands (4.9K tons), Spain (3.1K tons), India (3K tons), France (2.8K tons), Canada (2.7K tons) and Argentina (2.3K tons) represented the major exporters of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, together mixing up 64% of total exports. Australia (1.9K tons), Denmark (1.3K tons), Italy (1.2K tons), Germany (1K tons), Uruguay (1K tons) and Ukraine (0.9K tons) followed a long way behind the leaders.

From 2012 to 2022, average annual rates of growth with regard to human and animal blood exports from the United States stood at +3.7%. At the same time, Uruguay (+36.5%), India (+35.5%), Ukraine (+31.0%), the Netherlands (+30.3%), Australia (+17.7%), Spain (+17.1%), Canada (+9.9%) and Italy (+2.5%) displayed positive paces of growth. Moreover, Uruguay emerged as the fastest-growing exporter exported in the world, with a CAGR of +36.5% from 2012-2022. By contrast, Argentina (-2.4%), Germany (-9.7%), France (-10.2%) and Denmark (-10.7%) illustrated a downward trend over the same period. From 2012 to 2022, the share of the Netherlands, India, Spain, the United States, Canada, Australia, Uruguay and Ukraine increased by +9.6, +6.1, +5.1, +4.3, +3.2, +3.1, +1.9 and +1.9 percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the United States ($1.7B) remains the largest human and animal blood supplier worldwide, comprising 26% of global exports. The second position in the ranking was taken by France ($390M), with a 6.2% share of global exports. It was followed by the Netherlands, with a 5.5% share.

In the United States, human and animal blood exports increased at an average annual rate of +9.0% over the period from 2012-2022. The remaining exporting countries recorded the following average annual rates of exports growth: France (+1.4% per year) and the Netherlands (+22.3% per year).

Export Prices By Country

The average human and animal blood export price stood at $134,673 per ton in 2022, with a decrease of -29.8% against the previous year. Overall, export price indicated a pronounced increase from 2012 to 2022: its price increased at an average annual rate of +2.9% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, human and animal blood export price increased by +59.3% against 2014 indices. The most prominent rate of growth was recorded in 2021 an increase of 47% against the previous year. As a result, the export price reached the peak level of $191,946 per ton, and then fell remarkably in the following year.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Germany ($308,068 per ton), while Uruguay ($3,436 per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by France (+12.9%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Market Intelligence Platform